ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,591Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 1111

$646K Total Retail Price of All Prescriptions

Rank: 124 out of 1111

674 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 674 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

35% of this provider’s 674 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

4% of this provider’s 11,000 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 1,005 447 S3 1 1
FUROSEMIDE 661 527 2 6
OMEPRAZOLE 546 414 3 4
LISINOPRIL 449 288 4 2
POTASSIUM CHLORIDE 406 298 5 9
LEVOTHYROXINE SODIUM 401 318 6 3
METFORMIN HCL 376 265 7 8
SIMVASTATIN 358 267 8 5
METOPROLOL TARTRATE 328 245 9 12
CEPHALEXIN 316 177 10 89
AMLODIPINE BESYLATE 259 218 11 7
WARFARIN SODIUM 247 211 12 19
TRAMADOL HCL 241 141 13 13
ZOLPIDEM TARTRATE 240 115 14 16
CARISOPRODOL 225 39 R 15 54
LOVASTATIN 218 167 16 41
GABAPENTIN 209 118 17 10
HYDROCHLOROTHIAZIDE 207 143 18 11
RANITIDINE HCL 203 171 19 29
METHYLPREDNISOLONE 198 114 20 93
ATORVASTATIN CALCIUM 196 146 21 15
PROAIR HFA 187 97 22 38
CLOPIDOGREL 182 144 23 30
NEXIUM 178 105 24 26
GLYBURIDE 175 138 R 25 59
SERTRALINE HCL 174 105 26 24
ALENDRONATE SODIUM 174 159 26 35
TAMSULOSIN HCL 166 131 28 28
CARVEDILOL 155 104 29 21
MELOXICAM 151 112 30 18
METOPROLOL SUCCINATE 148 106 31 20
CYCLOBENZAPRINE HCL 147 49 R 32 37
DONEPEZIL HCL 144 144 33 25
PAROXETINE HCL 140 84 34 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 131 91 35 23
CIPROFLOXACIN HCL 129 102 36 58
POLYETHYLENE GLYCOL 3350 126 102 37 45
LOSARTAN POTASSIUM 113 83 38 34
PLAVIX 107 82 39 49
PANTOPRAZOLE SODIUM 104 68 40 50
GLIMEPIRIDE 97 83 41 61
ISOSORBIDE MONONITRATE ER 96 74 42 73
ROPINIROLE HCL 94 60 43 68
RISPERIDONE 93 56 44 60
MEGESTROL ACETATE 93 91 R 44 103
CLONIDINE HCL 93 42 44 42
DIGOXIN 86 83 47 47
CEFUROXIME 86 63 47 138
FLUOXETINE HCL 85 55 49 44
LYRICA 83 42 50 62
ACTOS 78 54 51 98
QUETIAPINE FUMARATE 77 50 52 76
ETODOLAC 75 21 53 137
PRAVASTATIN SODIUM 73 58 54 17
PROMETHAZINE HCL 73 12 R 54 69
CITALOPRAM HBR 73 49 54 14
AZITHROMYCIN 73 43 54 39
PREMARIN 72 49 R 58 90
ADVAIR DISKUS 72 57 58 43
SPIRONOLACTONE 71 49 60 83
PROPRANOLOL HCL 71 66 60 124
ACETAMINOPHEN-CODEINE 70 48 S3 62 140
DILTIAZEM HCL 69 37 63 242
LIPITOR 68 47 64 116
PREDNISONE 64 52 65 48
ENALAPRIL MALEATE 63 60 66 56
LOSARTAN-HYDROCHLOROTHIAZIDE 63 50 66 72
ALLOPURINOL 62 53 68 36
TRIAMCINOLONE ACETONIDE 62 44 68 128
FLUTICASONE PROPIONATE 61 40 70 27
CYMBALTA 60 28 71 40
LANTUS 59 30 72 46
SPIRIVA 58 33 73 53
NAPROXEN 58 21 73 85
GLIPIZIDE 58 49 73 57
CLOTRIMAZOLE-BETAMETHASONE 54 39 76 194
IBUPROFEN 53 29 77 66
VERAPAMIL ER 53 44 77 100
FLUCONAZOLE 52 29 79 195
AMITRIPTYLINE HCL 50 38 R 80 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.